Non-Current Assets

Long-term marketable securities

Bristol-Myers Squibb Long-term marketable securities decreased by 7.6% to $366.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $344.00M to $366.00M.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.

Detailed definition

This represents long-term investments in debt securities that the company intends to hold for more than one year. These...

Peer comparison

Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.

Metric ID: non_current_assets_available_for_sale_securities_debt_se_908f76

Historical Data

11 periods
 Q4 '22Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$364.00M$367.00M$357.00M$324.00M$320.00M$344.00M$346.00M$406.00M$396.00M$366.00M
QoQ Change+0.8%-2.7%-9.2%-1.2%+7.5%+0.6%+17.3%-2.5%-7.6%
YoY Change-12.1%-6.3%-3.1%+25.3%+23.8%+6.4%
Range$0.00$406.00M
Avg YoY Growth+5.7%
Median YoY Growth+1.7%
Current Streak2 quarters decline

Long-term marketable securities at Other Companies

Frequently Asked Questions

What is Bristol-Myers Squibb's long-term marketable securities?
Bristol-Myers Squibb (BMY) reported long-term marketable securities of $366.00M in Q1 2026.
How has Bristol-Myers Squibb's long-term marketable securities changed year-over-year?
Bristol-Myers Squibb's long-term marketable securities increased by 6.4% year-over-year, from $344.00M to $366.00M.
What does long-term marketable securities mean?
Long-term investments in debt securities held for interest income.